Redwood Trust Inc RWT Q1 2026 Earnings EPS Misses Estimates Amidst Quiet Market Reaction SPCE Q1 2026 Earnings Narrower Loss Beats Expectations as Stock Jumps Marker Therapeutics Q1 2026 Earnings Loss Narrows as Clinical Progress Continues Metas Workforce Reduction Signals Strategic Pivot Toward Artificial Intelligence Compass Therapeutics Q1 2026 Earnings Narrower Loss Beats Estimates as Pipeline Progress Takes Center Stage